News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Neural Therapeutics Announces CSE Application to Acquire Full Ownership of Hanf.com, Shareholder Meeting, SIO Agreement Amendment and Concurrent Financing
February 19, 2026
·
8 min read
Press Releases
Kiora Pharmaceuticals to Present at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference
February 19, 2026
·
1 min read
Press Releases
Nextleaf Solutions Scales up CPG Brand Growth with an Enhanced National Commercial Platform
February 19, 2026
·
6 min read
Press Releases
Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement
February 19, 2026
·
3 min read
Press Releases
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
February 19, 2026
·
10 min read
Press Releases
Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression
February 19, 2026
·
5 min read
Press Releases
Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894
February 19, 2026
·
5 min read
Press Releases
Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC
February 18, 2026
·
5 min read
Press Releases
Marvel Biosciences Secures Funding to Develop Child-Friendly Liquid Formulation for Neurodevelopmental Disorders
February 18, 2026
·
4 min read
Press Releases
Telo Genomics Closes First Tranche of Convertible Debentures Financing
February 18, 2026
·
4 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us